1.
Ashwani K. Dhingra, Rupa Devi, Seema Pegowal, Ankita Rajput, Varinder Kaur, Jasmeen Kaur, et al. The future of cancer immunotherapy: Advances in checkpoint inhibitors and chimeric antigen receptor-T cells discussing recent progress in immunotherapy for cancer, focusing on checkpoint inhibitors and chimeric antigen receptor-T cell therapies. Inn Phar Plan [Internet]. 2024 Dec. 9 [cited 2025 Sep. 19];12(4):69-72. Available from: https://www.innovationaljournals.com/index.php/ip/article/view/918